Lobe Sciences Ltd. (CVE:LOBE)

BRIEF

published on 06/18/2025 at 06:03, 8 months 2 days ago

Lobe Sciences Advances Conjugated Psilocin Development with Cynaptec Spin-Out

Conjugated Psilocin Cynaptec Pharmaceuticals Chronic Cluster Headaches Sickle Cell Disease Biopharmaceutical Investments
PRESS RELEASE

published on 06/18/2025 at 05:58, 8 months 2 days ago

Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M

Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™
BRIEF

published on 06/03/2025 at 12:15, 8 months 17 days ago

Lobe Sciences nomme Yong Yao au poste de directeur financier des initiatives stratégiques

Croissance Stratégique Expansion Opérationnelle Financement Des Biotechnologies Sciences Du Lobe Yong Yao
BRIEF

published on 06/03/2025 at 12:15, 8 months 17 days ago

Lobe Sciences Appoints Yong Yao as CFO for Strategic Initiatives

Strategic Growth Operational Expansion Biotech Finance Lobe Sciences Yong Yao
PRESS RELEASE

published on 06/03/2025 at 12:10, 8 months 17 days ago

Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership

Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao
BRIEF

published on 04/14/2025 at 13:05, 10 months 6 days ago

Lobe Sciences lance un placement privé pour le développement de médicaments

Placement Privé Essais Cliniques Sciences Du Lobe Cynaptec Pharmaceuticals Psilocine Conjuguée
BRIEF

published on 04/14/2025 at 13:05, 10 months 6 days ago

Lobe Sciences Initiates Private Placement for Drug Development

Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
PRESS RELEASE

published on 04/14/2025 at 13:00, 10 months 6 days ago

Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases

Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec
BRIEF

published on 04/05/2025 at 05:55, 10 months 15 days ago

Lobe Sciences Provides Corporate Update on Recent Transactions

Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
BRIEF

published on 04/05/2025 at 05:55, 10 months 15 days ago

Lobe Sciences fournit une mise à jour de l'entreprise sur les transactions récentes

Essais Cliniques Billets Convertibles Commentaires De La FDA Sciences Du Lobe Mucate De Psilocine

Published on 02/20/2026 at 20:15, 1 hour 24 minutes ago

Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 1 hour 24 minutes ago

Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 3 hours 9 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 5 hours 54 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 7 hours 9 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 3 hours 2 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 3 hours 7 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 3 hours 15 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 3 hours 38 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 3 hours 38 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 2 hours 9 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 2 hours 9 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 3 hours 39 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 3 hours 39 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 4 hours 4 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News